Xeltis Hemodialysis Access (aXess) Conduit: aXess-E Study

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 16, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
End Stage Renal Disease
Interventions
DEVICE

aXess-E conduit

The aXess-E conduit is a sterile, regenerative biodegradable polymer-based vascular conduit, consisting of a tubular structure with a 6mm inner diameter. It is comprised of a highly porous polymer matrix and an embedded electropolished nitinol reinforcement layer (Strain Relief System). The aXess-E conduit is able to support both straight and loop configurations and may be implanted in the upper arm and forearm.

Trial Locations (2)

Unknown

RECRUITING

Hospital de Santa Maria, Lisbon

RECRUITING

Kliničko bolnički centar Zvezdara Klinika za Interne Bolesti, Belgrade

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Xeltis

INDUSTRY

NCT06329310 - Xeltis Hemodialysis Access (aXess) Conduit: aXess-E Study | Biotech Hunter | Biotech Hunter